The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J01 | Antibacterials for systemic use | |
| 3 | J01E | Sulfonamides and trimethoprim | |
| 4 | J01EC | Intermediate-acting sulfonamides |
| Code | Title | |
|---|---|---|
| J01EC01 | Sulfamethoxazole | |
| J01EC02 | Sulfadiazine | |
| J01EC03 | Sulfamoxole | |
| J01EC20 | Combinations |
| Active Ingredient | Description | |
|---|---|---|
| Sulfadiazine |
Sulfadiazine is an antibiotic that belongs to the class of drugs known as sulphonamides. Sulfadiazine is a structural analogue and competitive antagonist of p-aminobenzoic acid preventing bacterial utilisation of PABA in the synthesis of folic acid. |
|
| Sulfamethoxazole |
Sulfamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis. |
